Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial.
暂无分享,去创建一个
A. Roguin | D. Kandzari | D. Cutlip | R. Waksman | G. Doros | J. Koolen | J. Bennett | Elie G. Gharib | H. García-García | R. Waksman